Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.e

Organizing pneumonia pattern (an area or areas of consolidation on imaging)

Publications

Dimala CA, Patel U, Lloyd B, Donato A, Kimmel WB, Hallowell R, Moss C

A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins.

Case reports in pulmonology 2021;2021;9343491 — 2021 — 9343491

Watts A, Toquica Gahona CC, Raj K

Multifocal Pneumonia Amidst the Global COVID-19 Pandemic: A Case of Daptomycin-Induced Eosinophilic Pneumonia.

Cureus 2021 Jun;13;e16002 — 2021 Jun — e16002

Søndergaard TS, Schumacher H, Norup K

[Possible daptomycin-induced organizing pneumonia].

Ugeskrift for laeger 2010 Aug 09;172;2172-4 — 2010 Aug 09 — 2172-4

Cobb E, Kimbrough RC, Nugent KM, Phy MP

Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin.

The Annals of pharmacotherapy 2007 Apr;41;696-701 — 2007 Apr — 696-701